Our mission is to bring clarity and insights to the complex world of genomics, enabling better understanding, diagnosis, and treatment of rare genetic disorders and cancer.
With our cutting-edge technology and expertise, we are dedicated to making a positive impact on individuals and families affected by these conditions.
Our Integrated Services encompass the following steps:
We work closely with local labs, serving as our valued customers, to ensure the smooth collection and transportation of patient samples. Our dedicated team will provide the necessary instructions and support to facilitate the sample collection process.
Once the samples are received at our accredited partner labs, they undergo next-generation sequencing (NGS) using state-of-the-art equipment. Our collaboration with trusted lab partners ensures accurate and reliable sequencing results.
Our proprietary Owie™platform is at the forefront of data analysis for tertiary analysis. It utilizes advanced algorithms and bioinformatics tools to analyze the genomic data generated from NGS. This powerful platform enables us to efficiently identify genetic variants associated with rare diseases and oncology, providing valuable insights into their clinical significance.
Experienced Geneticists and Bioinformaticians: Our team of experienced geneticists and bioinformaticians are experts in analyzing and interpreting genomic data. They work closely with the Owieplatform to ensure accurate and comprehensive analysis, delivering clinically relevant insights.
We prepare comprehensive result reports that summarize the analysis, interpretation, and findings in a clear and concise manner. These reports include relevant clinical information, variant annotations, and recommendations to guide further diagnosis or treatment decisions.
Each final result report is reviewed and signed by a medical geneticist, ensuring the highest level of expertise and quality assurance.
Our integrated approach to genomic services , combined with the advanced capabilities of the Owie™platform, enables us to provide accurate and actionable insights into rare diseases and oncology. We are committed to delivering high-quality results that empower clinicians and researchers in their pursuit of precision medicine.
We prioritize data privacy and security, ensuring that genomic data is shared in compliance with all applicable regulations and ethical standards, while fostering collaboration and knowledge exchange among researchers and clinicians.
Comprehensive genomic analysis.
We utilize advanced genomic sequencing technologies and sophisticated bioinformatics tools to analyze genetic data and identify potential variants associated with rare diseases and oncology.
Our team of experts carefully analyzes genomic variants to determine their clinical significance, helping healthcare professionals make informed decisions about diagnosis and treatment. Genetic variant databases: We leverage comprehensive databases and resources to enhance the interpretation of genomic variants, increasing the accuracy and reliability of our findings.
Personalized treatment strategies.
By analyzing the genomic profile of patients, we assist healthcare providers in developing tailored treatment plans based on the specific genetic alterations driving their rare diseases or cancer.
We identify potential targeted therapies or clinical trials based on the genomic characteristics of the disease, enabling more effective and precise treatment options.
Through genomic analysis, we identify genetic markers that can predict disease progression, response to treatment, and overall patient outcomes.
Collaborative partnerships: We actively collaborate with research institutions, academic centers, and pharmaceutical companies to contribute to the advancement of genomic research and accelerate discoveries in rare diseases and oncology.
At Genexfy, We are committed to transforming healthcare through genomics, driving innovation, and empowering healthcare providers with valuable insights to improve patient outcomes in the field of rare diseases and oncology.
To learn more about our services and how we can collaborate to transform healthcare through genomics.
Octopus Owie™ is our flagship product, offering advanced genomic data analysis for a wide range of applications.